Affinia Therapeutics Presents New Data at American Society of Gene and Cell Therapy Annual Meeting
- Monday, May 16, 2022, 7:00
- Finance
- Add a comment
Data show pretreatment with IVIG can limit biodistribution of AAV9 vectors to peripheral tissues following direct CNS administration WALTHAM, Mass., May 16, 2022 /PRNewswire/ — Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed…
About the Author
adminasapcorp has written 41611 stories on this site.